
Please try another search
Investing.com - Mediwound (NASDAQ: MDWD) reported fourth quarter EPS of $-1.180, $0.63 worse than the analyst estimate of $-0.550. Revenue for the quarter came in at $11.6M versus the consensus...
MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company specializing in next-generation biotherapeutic solutions for tissue repair and regeneration, is pleased to announce the...
MediWound (MDWD) reported Q3 EPS of ($0.38), $0.28 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $14.87 million versus the consensus estimate of $4.6 million.
Investing.com - Mediwound (NASDAQ:MDWD) reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that topped expectations. Mediwound announced earnings per share of...
MediWound (MDWD) reported Q2 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $4.7 million versus the consensus estimate of $5.28 million.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review